The 8 most recent market catalysts affecting $CI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 4, 2026
Corporate Catalyst
Bearish
Impact 65
Jefferies Downgrades Cigna Group to Hold, Lowers Price Target to $307
Jefferies analyst David Windley downgraded Cigna Group (CI) from a 'Buy' to a 'Hold' rating and lowered the price target from $336 to $307. This move signals a less optimistic outl…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 65
Raymond James Downgrades Cigna Group to Outperform, Lowers Price Target to $320
Raymond James analyst John Ransom downgraded Cigna Group (CI) from 'Strong Buy' to 'Outperform' and lowered the price target from $350 to $320. This action signals a reduced level …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Guggenheim Maintains Buy on Cigna Group, Raises Price Target to $361
Guggenheim analyst Jason Cassorla has maintained a 'Buy' rating on Cigna Group (CI) and raised the price target from $338 to $361. This action signals a strong vote of confidence f…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Equal-Weight on Cigna Group, Raises Price Target to $310
Barclays analyst Andrew Mok maintained an 'Equal-Weight' rating on Cigna Group (CI) but raised the price target from $304 to $310. This indicates a slightly improved valuation pers…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions
Cigna's Q2 2026 results showed an earnings and revenue beat, leading to an upward revision of its full-year adjusted EPS guidance. This would typically be a positive catalyst. Howe…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 75
Cigna Group shares are trading lower. The company reported Q2 financial results.
The headline indicates a direct corporate catalyst for Cigna (CI), with its Q2 results driving immediate share price depreciation. This event is significant because Cigna is a majo…
Jul 30, 2026
Corporate Catalyst
Neutral
Impact 75
Cigna Group FY2026 Adj EPS expected to be more than $30.45 vs $30.41 Est
Cigna Group (CI) filed an 8-K disclosing that its fiscal year 2026 adjusted EPS is projected to be more than $30.45, exceeding the current analyst estimate of $30.41. This is a pos…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 92
Cigna Group Q2 Adj. EPS $7.78 Beats $7.60 Estimate, Sales $71.558B Beat $70.339B Estimate
Cigna Group's Q2 earnings and sales significantly surpassed analyst estimates, demonstrating strong financial performance. The adjusted EPS of $7.78 beat the $7.60 estimate by 2.37…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.